ORIAU
Orion Biotech Opportunities Corp. [ORIAU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ORIAU Stock Summary
In the News
ORIAU Financial details
Company Rating
-
Market Cap
217.4M
Income
4904.48B
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Dec 2022
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-0.08
Quick Ratio
3.93
Current Ratio
6.5
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
196.18K
EPS next Y
-
EPS next Q
-
EPS this Y
-2904.88%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
499.02%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
9%
ROE
10%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.0-10.635
52W High
-10%
52W Low
0%
RSI
46
Rel Volume
0.02
Avg Volume
201
Volume
5
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-
-
-
Volatility
0.62%, 0.62%
Prev Close
-12.02%
Price
9
Change
-
Company Profile
- Volume Average 201
- Market Capitalization 217.4M
- CEO Mr. Zuie-Chin Huang M.B.A.
- Headquarters New York,NY,US
- IPO Date 2021-05-11
-
Website
https://orionbiotechopportunities.com 
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
